Physician's Weekly: Emerging Therapeutic Approaches & Diagnostic Tools for Basal Cell Carcinoma A recent narrative review looks at the most effective and emerging options for diagnosing and treating basal cell carcinoma. Markets Insider: Verrica Pharmaceuticals Announces Acceptance of Late-Breaking Abstract Highlighting Potential Abscopal Effect of VP-315 for the Treatment of Basal Cell Carcinoma at the ... Verrica Pharmaceuticals Announces Acceptance of Late-Breaking Abstract Highlighting Potential Abscopal Effect of VP-315 for the Treatment of Basal Cell Carcinoma at the ...
Basal cell carcinoma (BCC) represents the most prevalent form of skin cancer, with research efforts increasingly focused on elucidating its molecular underpinnings and improving therapeutic strategies ... (Miami Beach, Florida) — Basal cell carcinoma, the most common type of skin cancer, can be effectively treated with a radioactive skin patch containing phosphorus 32, researchers said ... News Medical: Early immunotherapy shows higher response in advanced basal cell carcinoma A new study led by researchers at the Johns Hopkins Kimmel Cancer Center found that patients with advanced basal cell carcinoma (BCC) may benefit from receiving immunotherapy earlier in the course of ... Medicus Pharma (NASDAQ:MDCX) said on Friday it has submitted an application to the US Food and Drug Administration seeking orphan drug designation for its SkinJect therapy to treat basal cell ...
